-
1
-
-
41849113831
-
Gene therapy for osteosarcoma: Steps towards clinical studies
-
10.1211/jpp.60.4.0001 1:CAS:528:DC%2BD1cXkslSiur0%3D 18380911
-
C.R. Dass P.F. Choong 2008 Gene therapy for osteosarcoma: steps towards clinical studies J Pharm Pharmacol 60 4 405 413 10.1211/jpp.60.4.0001 1:CAS:528:DC%2BD1cXkslSiur0%3D 18380911
-
(2008)
J Pharm Pharmacol
, vol.60
, Issue.4
, pp. 405-413
-
-
Dass, C.R.1
Choong, P.F.2
-
2
-
-
70349101267
-
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
-
10.1038/onc.2009.175 1:CAS:528:DC%2BD1MXnslOjtb4%3D 19561643
-
M. Enomoto S. Hayakawa S. Itsukushima, et al. 2009 Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling Oncogene 28 36 3197 3208 10.1038/onc.2009.175 1:CAS:528:DC%2BD1MXnslOjtb4%3D 19561643
-
(2009)
Oncogene
, vol.28
, Issue.36
, pp. 3197-3208
-
-
Enomoto, M.1
Hayakawa, S.2
Itsukushima, S.3
-
3
-
-
65249183163
-
Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers
-
10.1158/1078-0432.CCR-08-2454 1:CAS:528:DC%2BD1MXksV2nsbw%3D
-
R. Meyer V. Fofanov A. Panigrahi, et al. 2009 Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers Clin Caner Res 15 80 2703 2710 10.1158/1078-0432.CCR-08-2454 1:CAS:528:DC%2BD1MXksV2nsbw%3D
-
(2009)
Clin Caner Res
, vol.15
, Issue.80
, pp. 2703-2710
-
-
Meyer, R.1
Fofanov, V.2
Panigrahi, A.3
-
4
-
-
54249107573
-
Regulation of estrogenic effects by beclin 1 in breast cancer cells
-
10.1158/0008-5472.CAN-07-5875 1:CAS:528:DC%2BD1cXhtF2msLzL 18829541
-
S. John I. Nayvelt H.C. Hsu, et al. 2008 Regulation of estrogenic effects by beclin 1 in breast cancer cells Cancer Res 68 19 7855 7863 10.1158/0008-5472.CAN-07-5875 1:CAS:528:DC%2BD1cXhtF2msLzL 18829541
-
(2008)
Cancer Res
, vol.68
, Issue.19
, pp. 7855-7863
-
-
John, S.1
Nayvelt, I.2
Hsu, H.C.3
-
5
-
-
0000906170
-
Induction of autophagy and inhibition of tumorigenesis by Beclin 1
-
10.1038/45257 1:CAS:528:DC%2BD3cXjslek 10604474
-
X.H. Liang S. Jackson M. Seaman, et al. 1999 Induction of autophagy and inhibition of tumorigenesis by Beclin 1 Nature 402 6762 672 676 10.1038/45257 1:CAS:528:DC%2BD3cXjslek 10604474
-
(1999)
Nature
, vol.402
, Issue.6762
, pp. 672-676
-
-
Liang, X.H.1
Jackson, S.2
Seaman, M.3
-
6
-
-
33847008972
-
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells
-
DOI 10.1038/sj.cdd.4402030, PII 4402030
-
M. Katayama T. Kawaguchi M.S. Berger, et al. 2007 DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells Cell Death Differ 14 3 548 558 10.1038/sj.cdd.4402030 1:CAS:528:DC%2BD2sXhslWhtr8%3D 16946731 (Pubitemid 46259962)
-
(2007)
Cell Death and Differentiation
, vol.14
, Issue.3
, pp. 548-558
-
-
Katayama, M.1
Kawaguchi, T.2
Berger, M.S.3
Pieper, R.O.4
-
7
-
-
58149088029
-
Induction of autophagic cell death by a noval molecule is increased by hypoxia
-
1:CAS:528:DC%2BD1MXmtlaksQ%3D%3D 18927491
-
M. Tafani L. Schito T. Anwar, et al. 2008 Induction of autophagic cell death by a noval molecule is increased by hypoxia Autophagy 4 8 1042 1053 1:CAS:528:DC%2BD1MXmtlaksQ%3D%3D 18927491
-
(2008)
Autophagy
, vol.4
, Issue.8
, pp. 1042-1053
-
-
Tafani, M.1
Schito, L.2
Anwar, T.3
-
8
-
-
0037089643
-
Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma
-
DOI 10.1002/cncr.10434
-
H.B. Salvensen I. Stefansson M.B. Kalvenes, et al. 2002 Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma Cancer 94 8 2185 2191 10.1002/cncr.10434 (Pubitemid 34411976)
-
(2002)
Cancer
, vol.94
, Issue.8
, pp. 2185-2191
-
-
Salvesen, H.B.1
Stefansson, I.2
Kalvenes, M.B.3
Das, S.4
Akslen, L.A.5
-
9
-
-
28244477646
-
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 Year experience at Rizzoli Institute, Italy
-
DOI 10.1016/j.ejca.2005.08.026, PII S0959804905007987
-
G. Bacci A. Longhi F. Fagioli, et al. 2005 Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy Eur J Cancer 41 18 2836 2845 10.1016/j.ejca.2005.08.026 1:CAS:528:DC%2BD2MXht1OntLzN 16298125 (Pubitemid 41713121)
-
(2005)
European Journal of Cancer
, vol.41
, Issue.18
, pp. 2836-2845
-
-
Bacci, G.1
Longhi, A.2
Fagioli, F.3
Briccoli, A.4
Versari, M.5
Picci, P.6
-
10
-
-
69449108112
-
Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI
-
10.2967/jnumed.109.063602 1:CAS:528:DC%2BD1MXhtFOrtbrP 19690035
-
G.J. Cheon M.S. Kim J.A. Lee, et al. 2009 Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI J Nucl Med 50 9 1435 1440 10.2967/jnumed.109.063602 1:CAS:528:DC%2BD1MXhtFOrtbrP 19690035
-
(2009)
J Nucl Med
, vol.50
, Issue.9
, pp. 1435-1440
-
-
Cheon, G.J.1
Kim, M.S.2
Lee, J.A.3
-
11
-
-
68849109737
-
Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J
-
10.1007/s00776-009-1347-6 1:CAS:528:DC%2BD1MXpsFemu7g%3D 19662473
-
Y. Iwamoto K. Tanaka K. Isu, et al. 2009 Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J J Orthop Sci 14 4 397 404 10.1007/s00776-009-1347-6 1:CAS:528:DC%2BD1MXpsFemu7g%3D 19662473
-
(2009)
J Orthop Sci
, vol.14
, Issue.4
, pp. 397-404
-
-
Iwamoto, Y.1
Tanaka, K.2
Isu, K.3
-
12
-
-
33845382521
-
Current strategies of chemotherapy in osteosarcoma
-
DOI 10.1007/s00264-006-0192-x
-
D. Carrle S.S. Bielack 2006 Current strategies of chemotherapy in osteosarcoma Int Orthop 30 6 445 451 10.1007/s00264-006-0192-x 16896870 (Pubitemid 44900550)
-
(2006)
International Orthopaedics
, vol.30
, Issue.6
, pp. 445-451
-
-
Carrle, D.1
Bielack, S.S.2
-
13
-
-
61949109199
-
Senescence and cell death pathways and their role in cancer therapeutic outcome
-
10.2174/092986709787002691 1:CAS:528:DC%2BD1MXjsFGqs7o%3D 19149578
-
M.V. Chiantore S. Vannucchi G. Mangino, et al. 2009 Senescence and cell death pathways and their role in cancer therapeutic outcome Curr Med Chem 16 3 287 300 10.2174/092986709787002691 1:CAS:528:DC%2BD1MXjsFGqs7o%3D 19149578
-
(2009)
Curr Med Chem
, vol.16
, Issue.3
, pp. 287-300
-
-
Chiantore, M.V.1
Vannucchi, S.2
Mangino, G.3
-
14
-
-
70350630733
-
The emerging role of autophagy in Parkinson's disease
-
10.1186/1756-6606-2-29 19754977
-
Z.H. Cheung N.Y. Ip 2009 The emerging role of autophagy in Parkinson's disease Mol Brain 2 1 29 10.1186/1756-6606-2-29 19754977
-
(2009)
Mol Brain
, vol.2
, Issue.1
, pp. 29
-
-
Cheung, Z.H.1
Ip, N.Y.2
-
15
-
-
68949173719
-
Autophagy in immune cell regulation and dysregulation
-
10.1007/s11882-009-0050-1 19671376
-
A. Chaturvedi S.K. Pierce 2009 Autophagy in immune cell regulation and dysregulation Curr Allergy Asthma Rep 9 5 341 346 10.1007/s11882-009-0050-1 19671376
-
(2009)
Curr Allergy Asthma Rep
, vol.9
, Issue.5
, pp. 341-346
-
-
Chaturvedi, A.1
Pierce, S.K.2
-
16
-
-
35348886043
-
Physiological functions of Atg6/Beclin 1: A unique autophagy-related protein
-
DOI 10.1038/cr.2007.78, PII CR200778
-
Y. Cao D.J. Klionsky 2007 Physiologic functions of Atg6/Beclin 1: a unique autophagy-related protein Cell Res 17 10 839 849 10.1038/cr.2007.78 1:CAS:528:DC%2BD2sXhtFKitLnI 17893711 (Pubitemid 47585112)
-
(2007)
Cell Research
, vol.17
, Issue.10
, pp. 839-849
-
-
Cao, Y.1
Klionsky, D.J.2
-
17
-
-
9144240441
-
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
-
1:CAS:528:DC%2BD3sXhtVSmtLvP 14638851
-
X. Qu J. Yu G. Bhagat, et al. 2003 Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene J Clin Invest 112 12 1809 1820 1:CAS:528:DC%2BD3sXhtVSmtLvP 14638851
-
(2003)
J Clin Invest
, vol.112
, Issue.12
, pp. 1809-1820
-
-
Qu, X.1
Yu, J.2
Bhagat, G.3
-
18
-
-
2442485884
-
Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of Beclin 1
-
DOI 10.1074/jbc.M313561200
-
E. Scarlatti C. Bauvy A. Ventruti, et al. 2004 Ceramide-mediated macroautophagy involves inhibits of protein kinase B and up-regulation of beclin 1 J Biol Chem 279 18 18384 18391 10.1074/jbc.M313561200 1:CAS:528: DC%2BD2cXjsVKnur4%3D 14970205 (Pubitemid 38623254)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.18
, pp. 18384-18391
-
-
Scarlatti, F.1
Bauvy, C.2
Ventruti, A.3
Sala, G.4
Cluzeaud, F.5
Vandewalle, A.6
Ghidoni, R.7
Codogno, P.8
-
19
-
-
0345166111
-
Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor
-
DOI 10.1073/pnas.2436255100
-
Z. Yue S. Jin C. Yang, et al. 2003 Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor Proc Natl Acad Sci USA 100 25 15077 15082 10.1073/pnas.2436255100 1:CAS:528:DC%2BD3sXpvFaqtbg%3D 14657337 (Pubitemid 37518019)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.25
, pp. 15077-15082
-
-
Yue, Z.1
Jin, S.2
Yang, C.3
Levine, A.J.4
Heintz, N.5
-
20
-
-
27644514227
-
Another way to die: Autophagic programmed cell death
-
DOI 10.1038/sj.cdd.4401777, PII 4401777
-
Y. Tsujimoto S. Shimizu 2005 Another way to die: autophagic programmed cell death Cell Death Differ 12 Suppl2 1528 1534 10.1038/sj.cdd.4401777 1:CAS:528:DC%2BD2MXhtFCjt7%2FL 16247500 (Pubitemid 41553989)
-
(2005)
Cell Death and Differentiation
, vol.12
, Issue.SUPPL. 2
, pp. 1528-1534
-
-
Tsujimoto, Y.1
Shimizu, S.2
-
21
-
-
33645112812
-
Rapamycin pre-treatment protects against apoptosis
-
10.1093/hmg/ddl036 1:CAS:528:DC%2BD28Xis1Shs70%3D 16497721
-
B. Ravikumar Z. Berger C. Vacher, et al. 2006 Rapamycin pre-treatment protects against apoptosis Hum Mol Genet 15 7 1209 1216 10.1093/hmg/ddl036 1:CAS:528:DC%2BD28Xis1Shs70%3D 16497721
-
(2006)
Hum Mol Genet
, vol.15
, Issue.7
, pp. 1209-1216
-
-
Ravikumar, B.1
Berger, Z.2
Vacher, C.3
-
22
-
-
10344262564
-
Role of Bcl-2 family proteins in a non-apoptopic programmed cell death dependent on autophagy genes
-
DOI 10.1038/ncb1192
-
S. Shimizu T. Kanaseki N. Mizushima, et al. 2004 Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nat Cell Biol 6 12 1221 1228 10.1038/ncb1192 1:CAS:528:DC%2BD2cXhtVarsL%2FJ 15558033 (Pubitemid 39625121)
-
(2004)
Nature Cell Biology
, vol.6
, Issue.12
, pp. 1221-1228
-
-
Shimizu, S.1
Kanaseki, T.2
Mizushima, N.3
Mizuta, T.4
Arakawa-Kobayashi, S.5
Thompson, C.B.6
Tsujimoto, Y.7
-
23
-
-
54249104991
-
Autophagy: A novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model
-
10.1158/0008-5472.CAN-08-1333 1:CAS:528:DC%2BD1cXhtF2msLrM 18829554
-
L.A. Lambert N. Qiao K.K. Hunt, et al. 2008 Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model Cancer Res 68 19 7966 7974 10.1158/0008-5472.CAN-08-1333 1:CAS:528:DC%2BD1cXhtF2msLrM 18829554
-
(2008)
Cancer Res
, vol.68
, Issue.19
, pp. 7966-7974
-
-
Lambert, L.A.1
Qiao, N.2
Hunt, K.K.3
-
24
-
-
14044277429
-
The molecular machinery of autophagy: Unanswered questions
-
DOI 10.1242/jcs.01620
-
D.J. Klionsky 2005 The molecular machinery of autophagy: unanswered questions J Cell Sci 118 pt1 7 18 10.1242/jcs.01620 1:CAS:528: DC%2BD2MXhsVCrtb4%3D 15615779 (Pubitemid 40277100)
-
(2005)
Journal of Cell Science
, vol.118
, Issue.1
, pp. 7-18
-
-
Klionsky, D.J.1
-
25
-
-
58049192897
-
Identification of Barkor as a mammalian autophagy-specific factor for Beclin1 and class III phosphatidylinositol 3-kinase
-
10.1073/pnas.0810452105 1:CAS:528:DC%2BD1cXhsFamu7zM 19050071
-
Q. Sun W. Fan K. Chen, et al. 2008 Identification of Barkor as a mammalian autophagy-specific factor for Beclin1 and class III phosphatidylinositol 3-kinase Proc Natl Acad Sci USA 105 49 19211 19216 10.1073/pnas.0810452105 1:CAS:528:DC%2BD1cXhsFamu7zM 19050071
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.49
, pp. 19211-19216
-
-
Sun, Q.1
Fan, W.2
Chen, K.3
|